These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 27370960)

  • 61. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway.
    Huang KF; Zhang GD; Huang YQ; Diao Y
    Int Immunopharmacol; 2012 Feb; 12(2):334-41. PubMed ID: 22182776
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway.
    Siwak DR; Shishodia S; Aggarwal BB; Kurzrock R
    Cancer; 2005 Aug; 104(4):879-90. PubMed ID: 16007726
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Gambogic acid induces apoptotic cell death in T98G glioma cells.
    Thida M; Kim DW; Tran TTT; Pham MQ; Lee H; Kim I; Lee JW
    Bioorg Med Chem Lett; 2016 Feb; 26(3):1097-1101. PubMed ID: 26631318
    [TBL] [Abstract][Full Text] [Related]  

  • 64. BAY 11-7082, a nuclear factor-κB inhibitor, induces apoptosis and S phase arrest in gastric cancer cells.
    Chen L; Ruan Y; Wang X; Min L; Shen Z; Sun Y; Qin X
    J Gastroenterol; 2014 May; 49(5):864-74. PubMed ID: 23846545
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Gambogic acid attenuates liver fibrosis by inhibiting the PI3K/AKT and MAPK signaling pathways via inhibiting HSP90.
    Yu Z; Jv Y; Cai L; Tian X; Huo X; Wang C; Zhang B; Sun C; Ning J; Feng L; Zhang H; Ma X
    Toxicol Appl Pharmacol; 2019 May; 371():63-73. PubMed ID: 30953615
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Thevebioside, the active ingredient of traditional Chinese medicine, promotes ubiquitin-mediated SRC-3 degradation to induce NSCLC cells apoptosis.
    Yao C; Su L; Zhang F; Zhu X; Zhu Y; Wei L; Jiao X; Hou Y; Chen X; Wang W; Wang J; Zhu X; Zou C; Zhu S; Xu Z
    Cancer Lett; 2020 Nov; 493():167-177. PubMed ID: 32829007
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Upregulation of ADAM12 contributes to accelerated cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) in Non-Hodgkin's Lymphoma.
    Yin H; Zhong F; Ouyang Y; Wang Q; Ding L; He S
    Hematology; 2017 Oct; 22(9):527-535. PubMed ID: 28395594
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Repressing MYC by targeting BET synergizes with selective inhibition of PI3Kα against B cell lymphoma.
    Chen ZQ; Cao ZR; Wang Y; Zhang X; Xu L; Wang YX; Chen Y; Yang CH; Ding J; Meng LH
    Cancer Lett; 2022 Jan; 524():206-218. PubMed ID: 34688842
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Gambogic acid induces cell apoptosis through endoplasmic reticulum stress triggered inhibition of Akt signaling pathways in extranodal NK/T-cell lymphoma cells.
    Peng W; Chen BA
    Chin J Nat Med; 2018 Sep; 16(9):693-699. PubMed ID: 30269846
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibition of tachykinin NK
    Bayati S; Bashash D; Ahmadian S; Safaroghli-Azar A; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Eur J Pharmacol; 2016 Nov; 791():274-283. PubMed ID: 27609608
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification of 11(13)-dehydroivaxillin as a potent therapeutic agent against non-Hodgkin's lymphoma.
    Xiao X; Li H; Jin H; Jin J; Yu M; Ma C; Tong Y; Zhou L; Lei H; Xu H; Zhang W; Liu W; Wu Y
    Cell Death Dis; 2017 Sep; 8(9):e3050. PubMed ID: 28906487
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A novel histone deacetylase inhibitor Chidamide induces G0/G1 arrest and apoptosis in myelodysplastic syndromes.
    Liu Z; Ding K; Li L; Liu H; Wang Y; Liu C; Fu R
    Biomed Pharmacother; 2016 Oct; 83():1032-1037. PubMed ID: 27541047
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibition of SRC-3 enhances sensitivity of human cancer cells to histone deacetylase inhibitors.
    Zou Z; Luo X; Nie P; Wu B; Zhang T; Wei Y; Wang W; Geng G; Jiang J; Mi Y
    Biochem Biophys Res Commun; 2016 Sep; 478(1):227-233. PubMed ID: 27425252
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inducing cell cycle arrest and apoptosis by dimercaptosuccinic acid modified Fe3O4 magnetic nanoparticles combined with nontoxic concentration of bortezomib and gambogic acid in RPMI-8226 cells.
    Zhang W; Qiao L; Wang X; Senthilkumar R; Wang F; Chen B
    Int J Nanomedicine; 2015; 10():3275-89. PubMed ID: 25995634
    [TBL] [Abstract][Full Text] [Related]  

  • 75. N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma.
    Edwards SK; Moore CR; Liu Y; Grewal S; Covey LR; Xie P
    BMC Cancer; 2013 Oct; 13():481. PubMed ID: 24131623
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Suppression of BCL6 function by HDAC inhibitor mediated acetylation and chromatin modification enhances BET inhibitor effects in B-cell lymphoma cells.
    Cortiguera MG; García-Gaipo L; Wagner SD; León J; Batlle-López A; Delgado MD
    Sci Rep; 2019 Nov; 9(1):16495. PubMed ID: 31712669
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anti-tumor effects of the histone deacetylase inhibitor vorinostat on canine urothelial carcinoma cells.
    Eto S; Saeki K; Yoshitake R; Yoshimoto S; Shinada M; Ikeda N; Kamoto S; Tanaka Y; Kato D; Maeda S; Tsuboi M; Chambers J; Uchida K; Nishimura R; Nakagawa T
    PLoS One; 2019; 14(6):e0218382. PubMed ID: 31206526
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma.
    Zhang T; Guan XW; Gribben JG; Liu FT; Jia L
    Cell Death Dis; 2019 Apr; 10(5):330. PubMed ID: 30988279
    [TBL] [Abstract][Full Text] [Related]  

  • 79. 3-Methylcholanthrene, an AhR agonist, caused cell-cycle arrest by histone deacetylation through a RhoA-dependent recruitment of HDAC1 and pRb2 to E2F1 complex.
    Chang CC; Sue YM; Yang NJ; Lee YH; Juan SH
    PLoS One; 2014; 9(3):e92793. PubMed ID: 24658119
    [TBL] [Abstract][Full Text] [Related]  

  • 80. γ-Aminobutyric acid inhibits the proliferation and increases oxaliplatin sensitivity in human colon cancer cells.
    Song L; Du A; Xiong Y; Jiang J; Zhang Y; Tian Z; Yan H
    Tumour Biol; 2016 Nov; 37(11):14885-14894. PubMed ID: 27644246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.